Placental insufficiency and fetal growth restriction

Journal of Obstetrics and Gynecology of India

Volumn 61, Issue 5, 2011, Pages 505-511

  Krishna, Usha ^a,c   Bhalerao, Sarita ^b  

^a St Elizabeth's and Wadia Hospital ^*  (India)

^b B J WADIA HOSPITAL FOR CHILDREN   (India)

^c Breach Candy Bhatia and St Elizabeth's Hospitals   (India)

Author keywords

Colour doppler; IUGR; Low birth weight; Placental insufficiency

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; SILDENAFIL;

ALPHA TOCOPHEROL DEFICIENCY; AMNION FLUID; ANTIPHOSPHOLIPID SYNDROME; ASCORBIC ACID DEFICIENCY; BIPARIETAL DISTANCE; BLOOD VOLUME; BONE DEMINERALIZATION; BRADYCARDIA; CESAREAN SECTION; CHROMOSOME ABERRATION; DIET SUPPLEMENTATION; DISEASE SURVEILLANCE; DRUG MEGADOSE; DUCTUS VENOSUS; FETUS; FETUS DEATH; FETUS HEART RATE; FIRST TRIMESTER PREGNANCY; HORMONE DETERMINATION; HUMAN; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; LOW DRUG DOSE; MALARIA; MATERNAL BLOOD; MATERNAL HYPERTENSION; MIDDLE CEREBRAL ARTERY; NUTRITIONAL DEFICIENCY; OSTEOPOROSIS; OXIDATIVE STRESS; PERINATAL MORBIDITY; PLACENTA CIRCULATION; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SPONTANEOUS ABORTION; TACHYCARDIA; TROPHOBLAST; TUBERCULOSIS; UTERINE ARTERY; UTERUS FUNDUS HEIGHT; VAGINAL DELIVERY; VASCULAR DISEASE; VASCULAR RESISTANCE; WEIGHT GAIN;

EID: 84863434148     PISSN: 09719202     EISSN: 09756434     Source Type: Journal    
DOI: 10.1007/s13224-011-0092-x     Document Type: Review

References (17)

1. Karowicz-Bilinska A, Kedziora-Kornatowska K, Bartosz G. Indices of oxidative stress in pregnancy with fetal growth restriction. Informa Health Care. 2007;41:870-3. (Pubitemid 47180673)
2. France J. Biochemical prediction of the low birth weight growth restricted baby. In: Tambyraja and Mongelli, editors. The low birth weight baby. Obstetrics and gynecology in perspective. Hyderabad: Orient Longman Private Limited; 2003.
3. Otiv S, Coyaji K. Fetal growth restriction. In: Krishna U, Shah D, Salvi V, Sheriar N, Damania K, editors. Pregnancy at risk. 5th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd.; 2010.
4. Zimmermann P, Eirio V, Koskinen J, et al. Doppler assessment of the uterine and uteroplacental circulation in the second trimester in pregnancies at high risk for pre-eclampsia and or intrauterine growth retardation: comparison between different Doppler parameters. Ultrasound Obstet Gynecol. 2001;18:441-9.
5. Dhand H, Kumar KH, Dave A. Middle cerebral artery Doppler indices better predictor for fetal outcome in IUGR. J Obstet Gynecol India. 2011;61:166-71.
6. O'Neill AM, Burd ID, Sabogal JC, et al. Doppler ultrasound in obstetrics: current advances. In: Studd J, editors. Progress in obstetrics and gynaecology. 17th ed. New Delhi: Elsevier; 2007.
7. Damodaram M, Story L, Eixarch E, et al. Placental MRI in fetal growth restriction. Placenta. 2010;31(6):491-8.
8. Gülmezoglu AM, Hofmeyr GJ. Bed rest in hospital for suspected impaired fetal growth. Cochrane Database Syst Rev. 2000;2:CD000034.
9. Ramakrishnan U, Stein AD, Parra-Cabrera S, Wang M, Imhoff-Kunsch B, Juárez-Márquez S, Rivera J, Martorell R. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull. 2010;31(2 Suppl):S108-16.
10. Neri I, Mazza V, Galassi MC, et al. Effects of L-arginine on utero-placental circulation in growth related fetuses. Acta Obstet et Gynecol Scand. 1996;75:208-212. (Pubitemid 26105273)
11. Rytlewski K, Olszanecki R, Lauterbach R, et al. Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. Basic Clin Pharmacol Toxicol. 2006;99(2):146-152. (Pubitemid 44213943)
12. Leitich H, Egarter C, Husslein P, et al. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol. 1997;104(4):450-9. (Pubitemid 27189685)
13. Maharaj CH, O'Toole D, Lynch T, et al. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries. Reprod Biol Endocrinol. 2009;7:34.
14. Von Dadelszen P, Dwinnell S, Magee LA, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG. 2011;118(5):624-8.
15. Jassawalla MJ. Reduced fetal movements: interpretation and action. J Obstet Gynecol India. 2011;61(2):141-3.
16. Daftary SN, Bhide AG. Fetal growth restriction. In: Fernando A, Daftary SN, Bhide AG, editors. Practical guide to high-risk pregnancy and delivery-a South Asian perspective. Noida: Elsevier; 2008.
17. Yam J, Chua S, Arulkumaran S. Fetal pulse oximetry. In: Arulkumaran S, Jenkins HML, editors. Perinatal asphyxia. Hyderabad: Orient Longman Limited; 2000.